FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.6486
+0.0116 (1.82%)
At close: Aug 1, 2025, 4:00 PM
0.6420
-0.0066 (-1.02%)
After-hours: Aug 1, 2025, 7:24 PM EDT

Company Description

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company.

It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials.

The company was founded in 2021 and is based in Houston, Texas.

FibroBiologics, Inc.
FibroBiologics logo
CountryUnited States
Founded2021
IPO DateJan 31, 2024
IndustryBiotechnology
SectorHealthcare
Employees13
CEOPeter O’Heeron

Contact Details

Address:
455 East Medical Center Boulevard, Suite 300
Houston, Texas 77598
United States
Phone281-651-5150
Websitefibrobiologics.com

Stock Details

Ticker SymbolFBLG
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$30.00
CIK Code0001958777
CUSIP Number31573L105
ISIN NumberUS31573L1052
Employer ID86-3329066
SIC Code2834

Key Executives

NamePosition
Peter O'HeeronFounder, Chairperson and Chief Executive Officer
Dr. Hamid Khoja Ph.D.Chief Scientific Officer
Ruben A. Garcia J.D.General Counsel
Jason D. Davis CPAChief Financial Officer

Latest SEC Filings

DateTypeTitle
Jul 31, 202510-QQuarterly Report
Jul 18, 20258-K/A[Amend] Current report
Jul 18, 20258-KCurrent Report
Jul 17, 2025SCHEDULE 13G/AFiling
Jul 3, 20258-KCurrent Report
Jun 16, 20258-KCurrent Report
Jun 13, 20258-KCurrent Report
Jun 9, 20258-KCurrent Report
Jun 6, 2025SCHEDULE 13GFiling
May 14, 202510-QQuarterly Report